www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for September, 2009

The N.C. Division of Health Service Regulation has given Cary Urology approval to build a $9.85 million prostate-cancer center in Raleigh.

Lees meer..

  • 0 Comments
  • Filed under: 3
  • Northern Kentucky University has received a funding extension from the National Institutes of Health as part of a Kentucky IDeA Network of Biomedical Research Excellence grant.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Carolina HealthCare System’s plan to build a $9.2 million center to treat prostate cancer has been denied by state regulators.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Surgeons at the Methodist University Hospital Transplant Institute and the University of Tennessee Health Science Center performed the 1,000 liver transplant Sept. 28.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • St. Vincent’s Health System has agreed to pay nearly $2 million to the federal government to settle a Medicare fraud case.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • The National Cancer Institute has awarded $9.1 million to Boston University’s School of Medicine to extend The Black Women’s Health Study at the Slone Epidemiology Center.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Kentucky Attorney General Jack Conway filed suit Monday in Franklin Circuit Court against Merck & Co., alleging violations of the state’s consumer-protection laws over the company’s marketing of anti-inflammatory drug Vioxx.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Ohio State University Medical Center is teaming up with a New Jersey research institute for a project that will give 2,000 patients in the area a detailed look at their genetic make-up that researchers hope could help reduce the risk of some diseases.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Anxiety over a potential H1N1 epidemic is rising, as a majority of Americans believe the virus is a serious health hazard, according to a new survey.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Vitae Pharmaceuticals Inc. received an $8 million milestone payment from German drug company Boehringer Ingelheim as part of the companies’ partnership to develop new drugs to treat diabetes and metabolic diseases.

    Lees meer..

  • 0 Comments
  • Filed under: 3